These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8780396)

  • 1. Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-beta 1.
    Petzelbauer E; Springhorn JP; Tucker AM; Madri JA
    Am J Pathol; 1996 Sep; 149(3):923-31. PubMed ID: 8780396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-beta 1 correlates with reciprocal effects on cell migration.
    Basson CT; Kocher O; Basson MD; Asis A; Madri JA
    J Cell Physiol; 1992 Oct; 153(1):118-28. PubMed ID: 1522126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of endothelial cell overexpression of plasminogen activator inhibitor-1 on smooth muscle cell migration.
    Proia RR; Nelson PR; Mulligan-Kehoe MJ; Wagner RJ; Kehas AJ; Powell RJ
    J Vasc Surg; 2002 Jul; 36(1):164-71. PubMed ID: 12096275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
    Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA
    Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-beta 1.
    Iruela-Arispe ML; Sage EH
    J Cell Biochem; 1993 Aug; 52(4):414-30. PubMed ID: 7693728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cells modulate smooth muscle cell morphology by inhibition of transforming growth factor-beta 1 activation.
    Nackman GB; Bech FR; Fillinger MF; Wagner RJ; Cronenwett JL
    Surgery; 1996 Aug; 120(2):418-25; discussion 425-6. PubMed ID: 8751613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture.
    Yamamoto H; Ueno H; Ooshima A; Takeshita A
    J Biol Chem; 1996 Jul; 271(27):16253-9. PubMed ID: 8663151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration.
    Kojima S; Harpel PC; Rifkin DB
    J Cell Biol; 1991 Jun; 113(6):1439-45. PubMed ID: 1828468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1.
    Redmond EM; Cullen JP; Cahill PA; Sitzmann JV; Stefansson S; Lawrence DA; Okada SS
    Circulation; 2001 Jan; 103(4):597-603. PubMed ID: 11157728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillar collagen regulation of plasminogen activator inhibitor-1 is involved in altered smooth muscle cell migration.
    Tanaka S; Koyama H; Ichii T; Shioi A; Hosoi M; Raines EW; Nishizawa Y
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1573-8. PubMed ID: 12377732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties.
    Al-Fakhri N; Chavakis T; Schmidt-Wöll T; Huang B; Cherian SM; Bobryshev YV; Lord RS; Katz N; Preissner KT
    Biol Chem; 2003 Mar; 384(3):423-35. PubMed ID: 12715893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coculture conditions alter endothelial modulation of TGF-beta 1 activation and smooth muscle growth morphology.
    Powell RJ; Bhargava J; Basson MD; Sumpio BE
    Am J Physiol; 1998 Feb; 274(2):H642-9. PubMed ID: 9486269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells.
    Pollman MJ; Naumovski L; Gibbons GH
    Circulation; 1999 Apr; 99(15):2019-26. PubMed ID: 10209007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis.
    Brown SL; Lundgren CH; Nordt T; Fujii S
    Cardiovasc Res; 1994 Dec; 28(12):1815-20. PubMed ID: 7532547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta is activated by plasmin and inhibits smooth muscle cell death in human saphenous vein.
    George SJ; Johnson JL; Smith MA; Angelini GD; Jackson CL
    J Vasc Res; 2005; 42(3):247-54. PubMed ID: 15870504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta regulates increased ductus arteriosus endothelial glycosaminoglycan synthesis and a post-transcriptional mechanism controls increased smooth muscle fibronectin, features associated with intimal proliferation.
    Boudreau N; Clausell N; Boyle J; Rabinovitch M
    Lab Invest; 1992 Sep; 67(3):350-9. PubMed ID: 1405493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor beta 2.
    Sankar S; Mahooti-Brooks N; Centrella M; McCarthy TL; Madri JA
    J Biol Chem; 1995 Jun; 270(22):13567-72. PubMed ID: 7768960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.